Technical Analysis for ATH - Alterity Therapeutics Limited
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | -11.11% | |
180 Bullish Setup | Bullish Swing Setup | -11.11% | |
Wide Bands | Range Expansion | -11.11% | |
20 DMA Resistance | Bearish | 0.00% | |
50 DMA Resistance | Bearish | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Gapped Up | Strength | 0.00% | |
20 DMA Resistance | Bearish | 0.00% | |
50 DMA Resistance | Bearish | 0.00% | |
Wide Bands | Range Expansion | 0.00% |
Alert | Time |
---|---|
Down 10% | about 2 hours ago |
Gap Up Closed | about 2 hours ago |
Upper Bollinger Band Resistance | about 2 hours ago |
Reversed from Up | about 2 hours ago |
50 DMA Resistance | about 2 hours ago |
Get a Trading Assistant
Alterity Therapeutics Limited Description
Alterity Therapeutics Limited, formerly Prana Biotechnology Limited, is a development-stage medical biotechnology company. The Company is engaged in the research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's disease, Huntington disease, Parkinson's disease and other neurological disorders. The Company's lead product candidates are PBT2 and PBT434. The Company's lead drug candidate PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. The Company also has advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing. Its other applications for its therapies include certain cancers, age-related macular degeneration, Motor Neuron disease, Creutzfeldt-Jakob disease (the human variant of Mad Cow disease), and a range of orphan neurodegenerative disorders.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Disease Cancer Diseases Drugs Biology Cancers Disorders Geriatrics Neuroscience Psychiatric Diagnosis Alzheimer's Disease Macular Degeneration Neurological Disorders Parkinson Brain Cancer Degenerative Disease Medical Biotechnology Neurodegeneration Parkinson's Disease
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 0.009 |
52 Week Low | 0.003 |
Average Volume | 13,393,443 |
200-Day Moving Average | 0.006 |
50-Day Moving Average | 0.005 |
20-Day Moving Average | 0.004 |
10-Day Moving Average | 0.004 |
Average True Range | 0.001 |
RSI (14) | 51.22 |
ADX | 21.26 |
+DI | 21.739 |
-DI | 17.391 |
Chandelier Exit (Long, 3 ATRs) | 0.003 |
Chandelier Exit (Short, 3 ATRs) | 0.005 |
Upper Bollinger Bands | 0.005 |
Lower Bollinger Band | 0.003 |
Percent B (%b) | 0.69 |
BandWidth | 38.095 |
MACD Line | 0.000 |
MACD Signal Line | 0.000 |
MACD Histogram | 0.0 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.005 | ||||
Resistance 3 (R3) | 0.005 | 0.005 | 0.005 | ||
Resistance 2 (R2) | 0.005 | 0.005 | 0.005 | 0.005 | |
Resistance 1 (R1) | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 |
Pivot Point | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 |
Support 1 (S1) | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 |
Support 2 (S2) | 0.004 | 0.004 | 0.004 | 0.004 | |
Support 3 (S3) | 0.004 | 0.004 | 0.004 | ||
Support 4 (S4) | 0.004 |